Judge rejects Oscar’s request for injunction against Florida Blue in spat over broker agreements 

Wooden gavel and gold legal scale that appear to have sunlight falling on them
A judge for the Middle District of Florida said that Oscar failed to prove that actions taken by Florida Blue caused “irreparable harm” to its business. (Getty Images/William_Potter)

A Florida judge has rejected Oscar Health’s request for an injunction that would block Florida Blue from reaching exclusive agreements with insurance brokers. 

Oscar filed suit against Blue Cross Blue Shield of Florida in November, alleging that the insurer engaged in anticompetitive practices by monopolizing these brokers and preventing Oscar from growing its exchange business in the state. Its injunction request followed shortly thereafter

However, in the ruling (PDF), Paul Byron, a judge for the Middle District of Florida, said that Oscar failed to prove that actions taken by Florida Blue caused “irreparable harm” to its business. 

Free Daily Newsletter

Like this story? Subscribe to FierceHealthcare!

The healthcare sector remains in flux as policy, regulation, technology and trends shape the market. FierceHealthcare subscribers rely on our suite of newsletters as their must-read source for the latest news, analysis and data impacting their world. Sign up today to get healthcare news and updates delivered to your inbox and read on the go.

“The Court is unpersuaded by Oscar’s argument that Florida Blue’s exclusivity policy is responsible for the market share obtained in Orlando in the first year of competition,” Byron wrote. 

RELATED: Oscar files to expand ACA exchange footprint in 2019 

In its request, Oscar argued that Florida Blue’s dealings led directly to its failure to sell enough plans in Orlando, and that the agreements with brokers have also prevented it from expanding in Jacksonville and Tampa. An economist providing testimony in the case noted that the Blues plan holds a 91% market share in Orlando. 

That wasn’t enough to sway Byron on the injunction, however. For one, the judge ruled, Florida Blue offers a larger slate of plans in the state’s Affordable Care Act exchanges—including some plans without deductibles—and has broader provider networks, which could grow its market share. 

In addition, Byron said, another exchange competitor, Centene Corporation, has also carved out a notable market share in Florida, which indicates the current market is competitive. Centene’s enrollment has grown from about 8,300 members in 2014 to more than 371,000 members in 2018, the judge said. 

RELATED: ACA exchanges still dominated by narrow network pans 

Following Byron’s denial of the injunction, Florida Blue filed a motion (PDF) to have the case fully dismissed. 

“We believe that we presented compelling evidence to the court, and are pleased that Judge Byron found in Florida Blue’s favor,” the insurer said in a statement. 

In a statement, Oscar General Counsel Bruce Gottlieb said the insurer was “disappointed” by the decision. 

“We look forward to further pursuing our claims on the merits,” Gottlieb said. 

Suggested Articles

A group of House lawmakers want CMMI's mandatory kidney care model to be as narrow as possible and change how it calculates payments.

Humana and Microsoft announced a seven-year strategic partnership to build predictive solutions and intelligent automation to support Humana members.

Humana filed suit Friday against more than a dozen generic drugmakers alleging the companies engaged in price fixing.